Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients

被引：17

作者：

Glickman, Jacob W. ^{[1
,2
]}

Dubin, Celina ^{[1
,2
]}

Han, Joseph ^{[1
,2
]}

Dahabreh, Dante ^{[1
,2
]}

Garcet, Sandra ^{[3
]}

Krueger, James G. ^{[3
]}

Pavel, Ana B. ^{[1
,2
]}

Guttman-Yassky, Emma ^{[1
,2
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA

[3] Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10021 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2020年 / 145卷 / 04期

关键词：

D O I：

10.1016/j.jaci.2020.01.005

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1285 / 1288

页数：4

共 9 条

[1] Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial [J].

Bissonnette, Robert ;

Pavel, Ana B. ;

Diaz, Aisleen ;

Werth, John L. ;

Zang, Chuanbo ;

Vranic, Ivana ;

Purohit, Vivek S. ;

Zielinski, Michael A. ;

Vlahos, Bonnie ;

Estrada, Yeriel D. ;

Proulx, Etienne Saint-Cyr ;

Ports, William C. ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (05) :1274-1289

[2] Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab [J].

Brunner, Patrick M. ;

Pavel, Ana B. ;

Khattri, Saakshi ;

Leonard, Alexandra ;

Malik, Kunal ;

Rose, Sharon ;

On, Shelbi Jim ;

Vekaria, Anjali S. ;

Traidl-Hoffmann, Claudia ;

Singer, Giselle K. ;

Baum, Danielle ;

Gilleaudeau, Patricia ;

Sullivan-Whalen, Mary ;

Fuentes-Duculan, Judilyn ;

Li, Xuan ;

Zheng, Xiuzhong ;

Estrada, Yeriel ;

Garcet, Sandra ;

Wen, Huei-Chi ;

Gonzalez, Juana ;

Coats, Israel ;

Cueto, Inna ;

Neumann, Avidan U. ;

Lebwohl, Mark G. ;

Krueger, James G. ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (01) :142-154

[3] A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis [J].

Brunner, Patrick M. ;

Khattri, Saakshi ;

Garcet, Sandra ;

Finney, Robert ;

Oliva, Margeaux ;

Dutt, Riana ;

Fuentes-Duculan, Judilyn ;

Zheng, Xiuzhong ;

Li, Xuan ;

Bonifacio, Kathleen M. ;

Kunjravia, Norma ;

Coats, Israel ;

Cueto, Inna ;

Gilleaudeau, Patricia ;

Sullivan-Whalen, Mary ;

Suarez-Farinas, Mayte ;

Krueger, James G. ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) :169-178

[4] Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis [J].

Guttman-Yassky, Emma ;

Bissonnette, Robert ;

Ungar, Benjamin ;

Suarez-Farinas, Mayte ;

Ardeleanu, Marius ;

Esaki, Hitokazu ;

Suprun, Maria ;

Estrada, Yeriel ;

Xu, Hui ;

Peng, Xiangyu ;

Silverberg, Jonathan I. ;

Menter, Alan ;

Krueger, James G. ;

Zhang, Rick ;

Chaudhry, Usman ;

Swanson, Brian ;

Graham, Neil M. H. ;

Pirozzi, Gianluca ;

Yancopoulos, George D. ;

Hamilton, Jennifer D. D. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (01) :155-172

[5] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis [J].

Khattri, Saakshi ;

Brunner, Patrick M. ;

Garcet, Sandra ;

Finney, Robert ;

Cohen, Steven R. ;

Oliva, Margeaux ;

Dutt, Riana ;

Fuentes-Duculan, Judilyn ;

Zheng, Xiuzhong ;

Li, Xuan ;

Bonifacio, Kathleen M. ;

Kunjravia, Norma ;

Coats, Israel ;

Cueto, Inna ;

Gilleaudeau, Patricia ;

Sullivan-Whalen, Mary ;

Suarez-Farinas, Mayte ;

Krueger, James G. ;

Guttman-Yassky, Emma .

EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) :28-35

[6] Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology [J].

Khattri, Saakshi ;

Shemer, Avner ;

Rozenblit, Mariya ;

Dhingra, Nikhil ;

Czarnowicki, Tali ;

Finney, Robert ;

Gilleaudeau, Patricia ;

Sullivan-Whalen, Mary ;

Zheng, Xiuzhong ;

Xu, Hui ;

Cardinale, Irma ;

Strong, Cristina de Guzman ;

Gonzalez, Juana ;

Suarez-Farinas, Mayte ;

Krueger, Jim G. ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (06) :1626-1634

[7] Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis [J].

Pavel, Ana B. ;

Song, Teresa ;

Kim, Hyun-Je ;

Del Duca, Ester ;

Krueger, James G. ;

Dubin, Celina ;

Peng, Xiangyu ;

Xu, Hui ;

Zhang, Ning ;

Estrada, Yeriel D. ;

Denis, Louis ;

Rao, Niranjan ;

Gupta, Sandeep ;

Zammit, David J. ;

Bissonnette, Robert ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) :1011-1024

[8] Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response [J].

Sawyer, Laura M. ;

Malottki, Kinga ;

Sabry-Grant, Celia ;

Yasmeen, Najeeda ;

Wright, Emily ;

Sohrt, Anne ;

Borg, Emma ;

Warren, Richard B. .

PLOS ONE, 2019, 14 (08)

[9] Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response [J].

Tintle, Suzanne ;

Shemer, Avner ;

Suarez-Farinas, Mayte ;

Fujita, Hideki ;

Gilleaudeau, Patricia ;

Sullivan-Whalen, Mary ;

Johnson-Huang, Leanne ;

Chiricozzi, Andrea ;

Cardinale, Irma ;

Duan, Shenghui ;

Bowcock, Anne ;

Krueger, James G. ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (03) :583-U231

← 1 →